Leigh Morgan - Jul 6, 2022 Form 3 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Director
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol: KYMR
Transactions as of: Jul 6, 2022
Transactions value $: $0
Form type: 3
Date filed: 7/8/2022, 04:05 PM
Next filing: Jun 20, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney